86 related articles for article (PubMed ID: 11556340)
1. Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment.
Achard JM; Leborgne L; Tribouilloy C; Aldigier JC; Fournier A
Lancet; 2001 Sep; 358(9283):757-8; author reply 758-9. PubMed ID: 11556340
[No Abstract] [Full Text] [Related]
2. Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment.
Radke PW; Sigwart U
Lancet; 2001 Sep; 358(9283):757; author reply 758-9. PubMed ID: 11556341
[No Abstract] [Full Text] [Related]
3. Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition.
van Geel PP; Buikema H; Rouleau JL; van Gilst WH
Can J Cardiol; 2003 May; 19(6):701-4. PubMed ID: 12774785
[No Abstract] [Full Text] [Related]
4. Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment.
Ikeda U; Kurosaki K; Murakami Y; Shimada K
Lancet; 2001 Sep; 358(9283):758-9. PubMed ID: 11556342
[No Abstract] [Full Text] [Related]
5. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.
Meurice T; Bauters C; Hermant X; Codron V; VanBelle E; Mc Fadden EP; Lablanche J; Bertrand ME; Amouyel P
Lancet; 2001 Apr; 357(9265):1321-4. PubMed ID: 11343737
[TBL] [Abstract][Full Text] [Related]
6. [Effects of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): double-blind randomized trial].
Gnecchi M; Ardissino D
Ital Heart J Suppl; 2001 Sep; 2(9):1027-8. PubMed ID: 11675825
[No Abstract] [Full Text] [Related]
7. Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
Compr Ther; 1998 Jan; 24(1):38. PubMed ID: 9452901
[No Abstract] [Full Text] [Related]
8. Beneficial effect of quinapril in patients with angiotensin-converting enzyme D allele after coronary stenting.
Okumura K; Kamiya H; Matsui H; Sone T; Kondo J; Tsuboi H; Mukawa H
Atherosclerosis; 2001 Dec; 159(2):527-8. PubMed ID: 11730835
[No Abstract] [Full Text] [Related]
9. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II as an inflammatory mediator: evolving concepts in the role of the renin angiotensin system in the failing heart.
Mann DL
Cardiovasc Drugs Ther; 2002 Jan; 16(1):7-9. PubMed ID: 12085982
[No Abstract] [Full Text] [Related]
11. [Diabetic polyneuropathy and ACE gene polymorphism].
Yasuda H
Nihon Rinsho; 2005 Jun; 63 Suppl 6():652-6. PubMed ID: 15999786
[No Abstract] [Full Text] [Related]
12. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH
J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080
[TBL] [Abstract][Full Text] [Related]
13. Absence of association between angiotensin I-converting enzyme (ACE) DD genotype and the frequency of ACE inhibitor therapy.
Sigusch HH; Surber R; Vogt S; Müller S; Hoffmann A
Pharmazie; 1997 Jul; 52(7):565-6. PubMed ID: 9266596
[No Abstract] [Full Text] [Related]
14. Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitor.
Li X; Du Y; Du Y; Huang X
J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):25-30. PubMed ID: 12652327
[TBL] [Abstract][Full Text] [Related]
15. [Biohumoral and hemodynamic effects of angiotensin-converting enzyme inhibition in the hypertensive patient].
Marchegiano R; Raponi M; Lamenza F; Crispino MR; Morrone G; Trimarco C; Lembo G
Boll Soc Ital Biol Sper; 1988 Jul; 64(7):613-20. PubMed ID: 3228505
[No Abstract] [Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors in patients with atherosclerosis and preserved left ventricular function: clinical outcomes.
Pepine C
Can J Cardiol; 1998 Jul; 14 Suppl D():23D-26D. PubMed ID: 9713427
[No Abstract] [Full Text] [Related]
17. [Endothelium research. ACE inhibitor with high vascular affinity].
Riem L
MMW Fortschr Med; 2000 Jun; 142(22):56-7. PubMed ID: 10870387
[No Abstract] [Full Text] [Related]
18. Quinapril--a new angiotensin-converting enzyme inhibitor: an overview.
Dzau VI
Angiology; 1989 Apr; 40(4 Pt 2):329-30. PubMed ID: 2705641
[No Abstract] [Full Text] [Related]
19. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Strand JC; Bakovic-Alt R; Posvar EL
Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular profile of the ACE-inhibitor Quinapril. Worshop report. Freiburg in Breisgau, 15-16 May 1992].
Fortschr Med Monogr; 1992; 60():1-23. PubMed ID: 1366232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
